Phase 3 randomized COMMODORE 2 trial: Crovalimab versus eculizumab in patients with paroxysmal nocturnal hemoglobinuria naive to complement inhibition.
Jun Ho Jang, Fernando Silva, Bing Han, Jing Sun, Xiaoqin Wang, Guangsheng He, Je-Hwan Lee, Roberta Demichelis-Gómez, Martin Höglund, Chatree Chai-Adisaksopha, Alexander Röth, Hongyan Tong, Anna Gaya, Naoshi Obara, Chattree Hantaweepant, Sasha Sreckovic, Andres Brodsky, Teresita E Dumagay, Ponlapat Rojnuckarin, Richard J Kelly, Leigh Beveridge, Simon Buatois, Sammy Chebon, Pontus Lundberg, Zenghua Lin, Jun-Ichi Nishimura, Antonio Risitano, Brittany Gentile
American journal of hematology 2024;99(9):1768-1777